Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation‐Induced Lymphopenia
Cancer Medicine · 2026-01 · 15 (1)
DOI: 10.1002/cam4.71553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 22.01.2026. Verfasst von Yifu Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: PRaG Therapy Center, Center for Cancer Diagnosis and Treatment, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Lymphopenia, Spleen, Stomach Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Pioneer Talent Program of the Second Affiliated Hospital of Soochow University, Suzhou Major Disease Multicenter Clinical Research Project.
Abstract (Originalsprache)
Background
The spleen dose‐volume threshold for lymphopenia in abdominal radiotherapy has not yet reached a consensus. Our previous research indicated a correlation between these factors, but the threshold has not been determined. Therefore, we investigated the dynamic changes in lymphocytes during radiotherapy (RT), identified the spleen dose threshold, and examined how these factors affect patient prognosis.
Methods
The absolute lymphocyte counts (ALC) of gastric cancer patients were collected before, during, and after RT. Lymphocyte recovery status was assessed using the lymphocyte recovery index (LRI). LRI cut off was considered as insufficient recovery. Splenic dosimetric parameters were collected, and their impact on predicting grade 4 (G4) lymphopenia was evaluated using logistic regression analysis. Cox regression analysis was used to evaluate the relationship between lymphocyte depletion and recovery status and prognosis.
Results
159 patients were enrolled. The median ALC dropped by 85.71% after RT. The occurrence of G4 and G1‐3 lymphopenia was observed in 30.2% and 69.8% of cases, respectively. There were 12.6% of patients whose ALC had recovered at 120 days after RT, while the remaining 87.4% were still accompanied by lymphopenia. Cox multivariable analysis showed that pTNM stage and LRI were independent prognostic factors affecting overall survival, and the independent prognostic factors for disease‐free survival were pTNM stage and change in ALC. Splenic D mean and V 5 were related to G4 lymphopenia and eventually V 5 affected prognosis. Constraining the spleen V 5 to < 180.6 cm 3 and < 272.2 cm 3 may reduce the incidence of G4 lymphopenia and further decrease the risk of death by 60.9%.
Conclusions
Patients with severe lymphocyte decline during RT and insufficient lymphocyte recovery afterward have a worse prognosis. It is important not only to prevent severe lymphopenia during RT but also to focus on improving lymphocyte recovery after RT. Constraining the spleen V 5 is a key approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PRaG Therapy Center, Center for Cancer Diagnosis and Treatment, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Institute of Radiotherapy and Oncology, Soochow University, Suzhou, China.
- Department of Ultrasound, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Experimental Center, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
ORCID-Profile: Yifu Ma, Liyuan Zhang
Förderung
- National Natural Science Foundation of China
- Pioneer Talent Program of the Second Affiliated Hospital of Soochow University
- Suzhou Major Disease Multicenter Clinical Research Project
- Internal Collaborative Research Program of the State Key Laboratory of Radiation Medicine and Radiation Protection (jointly established by the Ministry of Scie…
Zitieren
APA
Ma, Y., Zhang, S., Ma, J., Gao, A., Liu, J., Ma, H., Zhou, Q., Qian, J., & Zhang, L. (2026). Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation‐Induced Lymphopenia. Cancer Medicine, 15(1). https://doi.org/10.1002/cam4.71553
Vancouver
Ma Y, Zhang S, Ma J, Gao A, Liu J, Ma H, et al. Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation‐Induced Lymphopenia. Cancer Medicine. 2026;15(1). doi:10.1002/cam4.71553
BibTeX
@article{Ma2026,
author = {Ma, Yifu and Zhang, Shuying and Ma, Jiayan and Gao, An and Liu, Jiale and Ma, He and Zhou, Qiyi and Qian, Jianjun and Zhang, Liyuan},
title = {Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation‐Induced Lymphopenia},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {1},
doi = {10.1002/cam4.71553}
}
EUVIMED